CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Myungmoon Pharm Co Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Myungmoon Pharm Co Ltd
Myeongmun Building
7 Gangnam-daero 54-gil, Gangnam-gu
Phone: +82 267112000p:+82 267112000 SEOUL, 06258  South Korea Ticker: 017180017180
Business Summary
Myungmoon Pharm Co Ltd is a Korea-based company primarily engaged in the manufacturing and sale of pharmaceuticals. The Company operates through two segments. The Pharmaceutical and Biotechnology segment is primarily involved in the manufacturing and sales of finished and raw pharmaceutical products, including treatments for hyperlipidaemia, degenerative joint diseases, digestive disorders, muscle relaxants, and anti-inflammatory analgesics, as well as the distribution of pharmaceuticals such as cognitive enhancers, reflux medications, muscle relaxants, and anti-inflammatory analgesics. The Service segment is primarily engaged in golf course operation and real estate development business.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
9/30/202512/31/2024Yes----

Industries
SIC Code Description
2834 Pharmaceutical preparations
2833 Medicinal chemicals and botanical products
7992 Public golf courses
6512 Operators of nonresidential buildings

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Co-Chief Executive Officer, Director Cheol HanBae 65 11/14/2017 11/14/2017
Co-Chief Executive Officer, Director Chun SikPark 55 11/14/2017 11/14/2017
Vice President, Managing Director Jae GeonHah 52
7 additional Officers and Directors records available in full report.

Business Names
Business Name
017180
Myungmoon pharmaceutical Co.,Ltd.
nuinTEK Co., Ltd. (Parent)

General Information
Number of Employees: 296 (As of 3/31/2025)
Outstanding Shares: 33,428,331 (As of 9/30/2025)
Shareholders: 22,510
Stock Exchange: KRX
Fax Number: +82 25725137


Copyright © 2026 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Tuesday, February 3, 2026